Qyuns Therapeutics Co., Ltd. (“QYUNS”) disclosed three new subscriptions of principal-guaranteed, floating-yield structured deposits offered by Shanghai Pudong Development Bank (PDB), committing a total principal of RMB270.00 million.

The subscriptions comprise: 1) RMB100.00 million in product 26JG7131, confirmed 29 Apr 2026 and maturing 29 Oct 2026; 2) RMB100.00 million in product 26JG7156, confirmed 6 May 2026 and maturing 6 Nov 2026; 3) RMB70.00 million in product 26JG7143, confirmed 6 May 2026 and maturing 6 Aug 2026.

Products 26JG7131 and 26JG7156 carry a guaranteed annual yield of 0.95% with potential floating returns of 0.85% (mid-range) or 1.05% (high-range). Product 26JG7143 offers a 0.70% guaranteed yield and potential floating returns of 0.70% (mid-range) or 0.90% (high-range). All three are classified by PDB as low-risk, principal-protected deposits.

Funding for the subscriptions is drawn from QYUNS’s internal cash resources, excluding IPO proceeds. Management cited the objective of enhancing returns on idle cash while preserving liquidity and risk control. The board stated that expected yields exceed standard bank deposit rates and that current internal controls ensure the transactions do not affect working capital.

Including a RMB100.00 million PDB structured deposit subscribed in March 2026, QYUNS’s cumulative commitments to similar products at the same bank reach RMB370.00 million within a 12-month period. Under Hong Kong Listing Rules, the aggregated amount classifies the latest subscriptions as discloseable transactions, triggering notification and announcement requirements.